Use of chlorhexidine to eradicate oropharyngeal SARS‐CoV‐2 in COVID‐19 patients
Y Hanna Huang, MD Jong T Huang
Journal of Medical Virology, doi:10.1002/jmv.26954
As public distribution of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is underway, prevention of coronavirus disease 2019 (COVID-19) relies on minimizing spread. In this study, chlorhexidine gluconate was investigated as a topical antimicrobial agent against SARS-CoV-2. This was a randomized, prospective cohort study using chlorhexidine as an oral rinse and posterior oropharyngeal spray in hospitalized COVID-19 patients. The primary outcome was presence or absence of laboratory-confirmed SARS-CoV-2 in the oral and oropharyngeal cavities after 4 days of chlorhexidine use and standard of care (study group) or standard of care only (control group). SARS-CoV-2 was eliminated from the oropharynx in 62.1% of patients who used chlorhexidine as an oral rinse, versus 5.5% of the control group patients. Among patients who used a combination of oral rinse and oropharyngeal spray, 86.0% eliminated oropharyngeal SARS-CoV-2, versus 6.3% of control patients. Chlorhexidine is a simple and safe addition to current COVID-19 prevention guidelines and may play a significant role in reducing disease spread.
CONFLICT OF INTERESTS The authors declare that there are no conflict of interests.
References
Anderson, Podgorny, Berríos-Torres, Strategies to prevent surgical site infections in acute care hospitals: 2014 update, Infect Control Hosp Epidemiol
Denton, Chlorhexidine, Disinfection, Sterilization and Preservation
Dhand, Li, Coughs and sneezes: their role in transmission of respiratory viral infections, including SARS-CoV-2, Am J Respir Crit Care Med
Firestone, Lorentz, Wang, First identified cases of SARS-CoV-2 variant B.1.1.7 in Minnesota -December 2020-January 2021, Morb Mortal Wkly Rep
Houston, Hougland, Anderson, Larocco, Kennedy et al., Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery, Am J Crit Care
Jones, Chlorhexidine: is it still the gold standard?, Periodontol
Khokhar, Roy, Purohit, Goyal, Setia, Viricidal treatments for prevention of coronavirus infection, Pathog Glob Health
Liu, Yan, Wan, Viral dynamics in mild and severe cases of COVID-19, Lancet Infect Dis
Meyers, Robison, Milici, Lowering the transmission and spread of human coronavirus, J Med Virol
Yoon, Yoon, Song, Clinical significance of a high SARS-CoV-2 viral load in the saliva, J Korean Med Sci
DOI record:
{
"DOI": "10.1002/jmv.26954",
"ISSN": [
"0146-6615",
"1096-9071"
],
"URL": "http://dx.doi.org/10.1002/jmv.26954",
"alternative-id": [
"10.1002/jmv.26954"
],
"archive": [
"Portico"
],
"assertion": [
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Received",
"name": "received",
"order": 0,
"value": "2020-12-25"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Accepted",
"name": "accepted",
"order": 1,
"value": "2021-03-17"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Published",
"name": "published",
"order": 2,
"value": "2021-04-01"
}
],
"author": [
{
"ORCID": "http://orcid.org/0000-0002-7949-5872",
"affiliation": [
{
"name": "Department of Medicine, Keck School of Medicine University of Southern California Los Angeles California USA"
}
],
"authenticated-orcid": false,
"family": "Huang",
"given": "Y. Hanna",
"sequence": "first"
},
{
"affiliation": [
{
"name": "Division of Infectious Diseases Good Samaritan Hospital Los Angeles California USA"
}
],
"family": "Huang",
"given": "Jong T.",
"sequence": "additional"
}
],
"container-title": [
"Journal of Medical Virology"
],
"content-domain": {
"crossmark-restriction": true,
"domain": [
"onlinelibrary.wiley.com"
]
},
"created": {
"date-parts": [
[
2021,
3,
23
]
],
"date-time": "2021-03-23T10:02:21Z",
"timestamp": 1616493741000
},
"deposited": {
"date-parts": [
[
2021,
6,
15
]
],
"date-time": "2021-06-15T06:23:39Z",
"timestamp": 1623738219000
},
"indexed": {
"date-parts": [
[
2021,
12,
22
]
],
"date-time": "2021-12-22T11:04:50Z",
"timestamp": 1640171090896
},
"is-referenced-by-count": 7,
"issn-type": [
{
"type": "print",
"value": "0146-6615"
},
{
"type": "electronic",
"value": "1096-9071"
}
],
"issue": "7",
"issued": {
"date-parts": [
[
2021,
4
]
]
},
"journal-issue": {
"issue": "7",
"published-print": {
"date-parts": [
[
2021,
7
]
]
}
},
"language": "en",
"license": [
{
"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
4,
1
]
],
"date-time": "2021-04-01T00:00:00Z",
"timestamp": 1617235200000
}
},
{
"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
4,
1
]
],
"date-time": "2021-04-01T00:00:00Z",
"timestamp": 1617235200000
}
}
],
"link": [
{
"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.26954",
"content-type": "application/pdf",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jmv.26954",
"content-type": "application/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.26954",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "311",
"original-title": [],
"page": "4370-4373",
"prefix": "10.1002",
"published": {
"date-parts": [
[
2021,
4
]
]
},
"published-online": {
"date-parts": [
[
2021,
4
]
]
},
"published-print": {
"date-parts": [
[
2021,
7
]
]
},
"publisher": "Wiley",
"reference": [
{
"key": "e_1_2_8_2_1",
"unstructured": "World Health Organization. Weekly Epidemiological Update – 2 March 2021.https://www.who.int/publications/m/item/weekly-epidemiological-update---2-march-2021. Accessed March 8 2021."
},
{
"DOI": "10.1080/20477724.2020.1807177",
"doi-asserted-by": "publisher",
"key": "e_1_2_8_3_1"
},
{
"key": "e_1_2_8_4_1",
"unstructured": "CDC. Coronavirus Disease 2019 (COVID‐19): How to Protect Yourself and Others. Atlanta GA: US Department of Health and Human Services CDC; 2020."
},
{
"DOI": "10.1177/0022034520967933",
"doi-asserted-by": "publisher",
"key": "e_1_2_8_5_1"
},
{
"DOI": "10.1002/jmv.26514",
"doi-asserted-by": "publisher",
"key": "e_1_2_8_6_1"
},
{
"DOI": "10.1086/676022",
"doi-asserted-by": "publisher",
"key": "e_1_2_8_7_1"
},
{
"DOI": "10.1111/j.1600-0757.1997.tb00105.x",
"doi-asserted-by": "publisher",
"key": "e_1_2_8_8_1"
},
{
"DOI": "10.4037/ajcc2002.11.6.567",
"doi-asserted-by": "publisher",
"key": "e_1_2_8_9_1"
},
{
"author": "Denton GW",
"first-page": "274",
"key": "e_1_2_8_10_1",
"volume-title": "Disinfection, Sterilization and Preservation",
"year": "1991"
},
{
"DOI": "10.3346/jkms.2020.35.e195",
"doi-asserted-by": "publisher",
"key": "e_1_2_8_11_1"
},
{
"DOI": "10.1016/S1473-3099(20)30232-2",
"doi-asserted-by": "publisher",
"key": "e_1_2_8_12_1"
},
{
"DOI": "10.1164/rccm.202004-1263PP",
"doi-asserted-by": "publisher",
"key": "e_1_2_8_13_1"
},
{
"DOI": "10.15585/mmwr.mm7008e1",
"doi-asserted-by": "publisher",
"key": "e_1_2_8_14_1"
}
],
"reference-count": 13,
"references-count": 13,
"relation": {},
"score": 1,
"short-container-title": [
"J Med Virol"
],
"short-title": [],
"source": "Crossref",
"subject": [
"Infectious Diseases",
"Virology"
],
"subtitle": [],
"title": [
"Use of chlorhexidine to eradicate oropharyngeal SARS‐CoV‐2 in COVID‐19 patients"
],
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1002/crossmark_policy",
"volume": "93"
}
